福利多元主义视角下我国慢性病医防融合工作多元主体协同状况分析

Multi-subject Collaborative Analysis of Medical Treatment and Prevention Integration Work of Chronic Disease in China from the Perspective of Welfare Pluralism

伴随现代工作与生活方式的改变,全球人群的高血压和糖尿病患病率都在持续升高,我国也不例外。因此,慢性病管理已成为公共卫生工作的重点任务。我国正在探索将“治病”和“防病”相结合的医防融合模式。由于医防融合工作涉及不同主体,各主体还需要财政与医保等政策的协同支持,因此,医防融合工作具有特殊性和复杂性,形成了适配性要求较高的多元主体供给形式。现阶段,医防融合工作在政策法规、体制建设、人才建设、医防观念等方面存在问题与不足,因此,积极探索构建由政府、医疗卫生机构、市场、社会、家庭和个人等多元福利主体构成的慢性病医防融合体系势在必行。本研究以福利多元主义理论为框架,聚焦慢性病医防融合工作多元主体,明确我国慢性病医防融合工作中各主体存在的问题,分析并提出若干建议,以期实现慢性病医防融合权责的合理配置,提高慢性病管理水平。

The global prevalence of hypertension and diabetes has continued to rise due to changes in modern work and lifestyle,and our country is no exception.As a result,chronic disease management has become a crucial task of public health work.China is exploring medical treatment and prevention integration model that combines treatment and prevention to transform the health service system from disease-centered to health-centered.The medical treatment and prevention integration work involves multiple subjects.The provision of medical treatment and prevention integration involves multiple subjects,each of which requires synergistic support from financial and medical insurance policies.As a result,the medical treatment and prevention integration service system is complex and has unique characteristics.It has being a multi-subject supply system that requires high adaptability.At this stage,there are challenges and shortcomings in medical treatment and prevention integration work in policy and regulatory issues,institutional and talent construction and so on.Therefore,it is imperative to actively pursue the establishment of a comprehensive chronic disease medical treatment and prevention integration service system involving government entities,healthcare institutions,the market,society,families,and individuals.Grounded in the theory of welfare pluralism,this research centers on the various stakeholders in medical treatment and prevention integration of chronic disease care.Its objective is to identify and address the challenges faced by each stakeholder within China's medical treatment and prevention integration,to conduct a thorough analysis,and to offer strategic recommendations.Ultimately,the aim is to achieve an equitable allocation of responsibilities and rights in medical treatment and prevention integration service,thereby improve the management of chronic disease care.